Arecor Therapeutics plc (AREC.L)
GBp 38.0
(0.0%)
GBp 38.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -9.17 Million GBP | 4.21% |
| 2022 | -10.63 Million GBP | -77.85% |
| 2021 | -5.97 Million GBP | -74.36% |
| 2020 | -3.42 Million GBP | -27.52% |
| 2019 | -2.68 Million GBP | 5.84% |
| 2018 | -2.85 Million GBP | -104.26% |
| 2017 | -1.39 Million GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -2.41 Million GBP | 0.0% |
| 2024 Q1 | -2.41 Million GBP | -14.55% |
| 2023 Q4 | -2.11 Million GBP | 0.0% |
| 2023 FY | -10.18 Million GBP | 4.21% |
| 2023 Q2 | -5.56 Million GBP | -124.58% |
| 2023 Q3 | -2.11 Million GBP | 62.08% |
| 2023 Q1 | -2.47 Million GBP | 59.42% |
| 2022 Q2 | -5.65 Million GBP | -116.41% |
| 2022 Q1 | -2.61 Million GBP | 35.79% |
| 2022 Q4 | -6.1 Million GBP | -138.8% |
| 2022 FY | -10.63 Million GBP | -77.85% |
| 2022 Q3 | -2.55 Million GBP | 54.81% |
| 2021 Q3 | -1.51 Million GBP | 49.78% |
| 2021 Q2 | -3 Million GBP | -103.5% |
| 2021 FY | -5.97 Million GBP | -74.36% |
| 2021 Q1 | -1.47 Million GBP | 32.7% |
| 2021 Q4 | -4.07 Million GBP | -169.53% |
| 2020 Q3 | -1.04 Million GBP | 38.04% |
| 2020 Q2 | -1.68 Million GBP | -151.09% |
| 2020 Q1 | -670.64 Thousand GBP | 0.0% |
| 2020 FY | -3.42 Million GBP | -27.52% |
| 2020 Q4 | -2.19 Million GBP | -110.48% |
| 2019 FY | -2.68 Million GBP | 5.84% |
| 2018 FY | -2.85 Million GBP | -104.26% |
| 2017 FY | -1.39 Million GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|